Published in Stat Med on January 15, 1992
Equipoise and the ethics of randomization. J R Soc Med (1995) 5.36
Clinical trials and rare diseases: a way out of a conundrum. BMJ (1995) 4.01
Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer. J Clin Oncol (2009) 0.84
Beyond the mega-trial: certainty and uncertainty. Br Heart J (1992) 0.75
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet (1992) 11.50
Sample size for studying intermediate endpoints within intervention trails or observational studies. Am J Epidemiol (1992) 6.92
Laparoscopic versus open inguinal hernia repair: randomised prospective trial. Lancet (1994) 6.91
Reliability of league tables of in vitro fertilisation clinics: retrospective analysis of live birth rates. BMJ (1998) 5.96
Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol (1994) 5.02
Bayesian approaches to random-effects meta-analysis: a comparative study. Stat Med (1995) 3.71
Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med (2002) 2.86
Screening for treatable diabetic retinopathy: a comparison of different methods. Diabet Med (1991) 2.76
Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome. Lancet (1992) 2.64
Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet (2004) 2.63
Monitoring of large randomised clinical trials: a new approach with Bayesian methods. Lancet (2001) 2.35
Mapping the densities of malaria vectors within a single village. Acta Trop (1995) 2.31
Statistical methodology for evaluating gastrointestinal symptoms. Clin Gastroenterol (1985) 2.29
Probabilistic prediction in patient management and clinical trials. Stat Med (1987) 2.10
Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J (1995) 2.09
Outcome in neonates with Ebstein's anomaly. J Am Coll Cardiol (1992) 1.99
Issues in data monitoring and interim analysis of trials. Health Technol Assess (2005) 1.96
Estimating the true extent of cognitive decline in the old old. J Am Geriatr Soc (1999) 1.90
The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee. Stat Med (1994) 1.90
Flexible random-effects models using Bayesian semi-parametric models: applications to institutional comparisons. Stat Med (2007) 1.90
A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Stat Med (1986) 1.82
Comparison of Bayesian with group sequential methods for monitoring clinical trials. Control Clin Trials (1989) 1.79
Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut (1994) 1.64
A relative cost-effectiveness analysis of different methods of screening for diabetic retinopathy. Diabet Med (1991) 1.55
Risk stratification for open heart surgery. BMJ (1992) 1.51
Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies. Health Econ (1992) 1.46
A database on dyspepsia. Gut (1994) 1.41
Use of risk-adjusted CUSUM and RSPRT charts for monitoring in medical contexts. Stat Methods Med Res (2003) 1.35
Management of women with a cervical smear showing a mild degree of dyskaryosis: a review of policy. Cytopathology (1992) 1.27
Computer aided decision making in medicine. Br Med J (Clin Res Ed) (1984) 1.24
Effects of an ambient air pollution intervention and environmental tobacco smoke on children's respiratory health in Hong Kong. Int J Epidemiol (1996) 1.23
Approximate cross-validatory predictive checks in disease mapping models. Stat Med (2003) 1.22
Setting the minimal metrically detectable change on disability rating scales. Arch Phys Med Rehabil (1997) 1.19
Cytomegalovirus infection in cardiac transplant recipients associated with chronic T cell subset ratio inversion with expansion of a Leu-7+ TS-C+ subset. Clin Exp Immunol (1985) 1.18
Survival analysis in observational studies. Stat Med (1997) 1.17
The what, why and how of Bayesian clinical trials monitoring. Stat Med (1994) 1.16
Estimation of population pharmacokinetics using the Gibbs sampler. J Pharmacokinet Biopharm (1995) 1.14
Monitoring clinical trials: conditional or predictive power? Control Clin Trials (1986) 1.14
An analysis of repeated biopsies following cardiac transplantation. Stat Med (1984) 1.14
Using routine intelligence to target inspection of healthcare providers in England. Qual Saf Health Care (2009) 1.12
Evaluation of a diagnostic algorithm for heart disease in neonates. BMJ (1991) 1.11
Domiciliary thrombolysis by general practitioners. BMJ (1992) 1.11
Breast cancer in thyroid disease: fact or fallacy? Lancet (1981) 1.08
Comparison between two districts of the effects of an air pollution intervention on bronchial responsiveness in primary school children in Hong Kong. J Epidemiol Community Health (1998) 1.02
How does computer-aided diagnosis improve the management of acute abdominal pain? Ann R Coll Surg Engl (1992) 1.02
Evaluation of clinical decision-aids, with an application to a system for dyspepsia. Stat Med (1984) 1.02
Changing patterns of coeliac disease frequency: an analysis of Coeliac Society membership records. Gut (1985) 1.00
Taking a calculated risk: predictive scoring systems in dyspepsia. Scand J Gastroenterol Suppl (1987) 0.95
Dopaminergic effects on electrophysiological and functional MRI measures of human cortical stimulus-response power laws. Neuroimage (2004) 0.94
Cardiac surgery for patients aged 65 years and older: a long term survival analysis. Br Heart J (1988) 0.93
A unified method for monitoring and analysing controlled trials. Stat Med (1994) 0.93
Two types of trichromatic squirrel monkey share a pigment in the red-green spectral region. Vision Res (1985) 0.91
The logical description of a disease class as a Boolean function with special reference to the irritable bowel syndrome. Clin Sci (Lond) (1984) 0.89
Surgical treatment of aortic coarctation in infants younger than three months: 1985 to 1990. Success of extended end-to-end arch aortoplasty. J Thorac Cardiovasc Surg (1994) 0.89
Intracortically distributed neurovascular coupling relationships within and between human somatosensory cortices. Cereb Cortex (2006) 0.88
Double-inlet ventricle presenting in infancy. I. Survival without definitive repair. J Thorac Cardiovasc Surg (1991) 0.87
How to interpret your dot: decoding the message of clinical performance indicators. J Perinatol (2008) 0.86
Evaluation of medical and managerial priorities in resource allocation: bone marrow transplantation at Westminster Hospital. Hosp Health Serv Rev (1983) 0.83
Statistical designs for investigating several interventions in the same study: methods for cancer prevention trials. J Natl Cancer Inst (1990) 0.83
Combining clinical judgement and statistical data in expert systems: over-the-telephone management decisions for critical congenital heart disease in the first month of life. Int J Clin Monit Comput (1989) 0.82
Variability of episodic ST segment depression in chronic stable angina: implications for individual and group trials of therapeutic efficacy. J Am Coll Cardiol (1994) 0.81
Double-inlet ventricle presenting in infancy. III. Outcome and potential for definitive repair. J Thorac Cardiovasc Surg (1991) 0.79
Trends in invasive cervical cancer incidence in East Anglia from 1971 to 1993. J Med Screen (1997) 0.79
An empirical comparison of expert-derived and data-derived classification trees. Stat Med (1996) 0.79
Pharmacodynamics of cyclosporine in heart and heart-lung transplant recipients. I: Blood cyclosporine concentrations and other risk factors for cardiac allograft rejection. Transplantation (1996) 0.77
Double-inlet ventricle presenting in infancy. II. Results of palliative operations. J Thorac Cardiovasc Surg (1991) 0.77
Computers and the diagnosis of acute abdominal pain. Br J Hosp Med (1989) 0.77
Prospective application of Bayesian monitoring and analysis in an "open" randomized clinical trial. Stat Med (2001) 0.76
Blood cyclosporine concentrations and cytomegalovirus infection following heart transplantation. Transplantation (1995) 0.76
Tricuspid atresia presenting in infancy. Survival and suitability for the Fontan operation. Circulation (1993) 0.76
Effects of environment and passive smoking on the respiratory health of children. Int J Epidemiol (1992) 0.75
Doctors' attitudes to risk in difficult clinical decisions: application of decision analysis in hepatobiliary disease. Br Med J (Clin Res Ed) (1984) 0.75
Blood cyclosporin concentrations and the short-term risk of lung rejection following heart-lung transplantation. Br J Clin Pharmacol (1992) 0.75
Monitoring the introduction of a surgical intervention with long-term consequences. Stat Med (2007) 0.75
Treatment decisions in breast cancer. Recent Results Cancer Res (1988) 0.75
'Rejection or infection' predictive value of T-cell subject ratio, before and after heart transplantation. J Heart Transplant (1987) 0.75
Pharmacodynamics of cyclosporine in heart and heart-lung transplant recipients. II: Blood cyclosporine concentrations and other risk factors for lung allograft rejection. Transplantation (1996) 0.75
Use of person-years of CIN III exposure as a surrogate outcome measure in cervical cancer screening trials. J Epidemiol Biostat (1999) 0.75
Thyroid disease and breast cancer. Lancet (1981) 0.75
Design and evaluation of a computer tool to aid early management of cyclosporine therapy after heart and heart-lung transplantation. Transplant Proc (1994) 0.75
Comparison of groups when outcomes are on an ordered scale. Aliment Pharmacol Ther (1988) 0.75
Comments on Lindberg's correction for the effects of observer variation on probabilistic diagnosis. Methods Inf Med (1982) 0.75